JCB logo
Quantitative Colocalization Analysis Software
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 9 June 2003. doi:10.1083/jcb1615iti5
This Article
Right arrow Full Text (PDF, 745K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dove, A. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dove, A. W.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/2003/6/833-b $5.00
The Journal of Cell Biology, Volume 161, Number 5, 833-b-833


In This Issue

Fusion promoter or fusion inhibitor?



Cells in fusogenic conditions (right) have less, rather than more, CD9 (green).

Mononuclear phagocytes can fuse to form osteoclasts or multinuclear giant cells. The latter are hallmarks of Crohn's disease, granulomas, tumors, and fungal and HIV infections. Though the precise function of these syncytia remains unclear, Takeda et al. (page 945) now provide important new insights into phagocyte fusion, suggesting that the process may differ considerably from other types of cell fusion.

Earlier work identified several cell surface proteins required for phagocyte fusion, but the authors focused on CD9 and CD81, transmembrane proteins in the tetraspanin family that promote the fusion of gametes, myoblasts, and virus-infected cells. Surprisingly, the expression of both proteins is elevated in mononuclear phagocytes cultured under normal conditions, but under fusogenic conditions CD9 and CD81 expression is reduced. Antibodies against either tetraspanin increase phagocyte fusion, and macrophages from mice lacking CD9 or CD81 have enhanced fusion capacity when stimulated.

Based on results from other cell types, CD9 and CD81 had been considered fusion promoters, but they apparently inhibit the process in phagocytes, indicating fundamental regulatory differences between macrophage and nonmacrophage fusion. The authors speculate that alterations in tetraspanin activity may contribute to the progression of diseases that involve multinuclear giant cells. {blacksquare}



Alan W. Dove

alanwdove{at}earthlink.net


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes
Yoshito Takeda, Isao Tachibana, Kenji Miyado, Masatoshi Kobayashi, Toru Miyazaki, Toshiki Funakoshi, Hiromi Kimura, Hiroyuki Yamane, Yoshiyuki Saito, Hiroyuki Goto, Tsutomu Yoneda, Mitsuhiro Yoshida, Toru Kumagai, Tadashi Osaki, Seiji Hayashi, Ichiro Kawase, and Eisuke Mekada
J. Cell Biol. 2003 161: 945-956. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 745K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dove, A. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dove, A. W.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents